Loading
NASDAQConsumer DefensiveAgricultural Farm Products
Latest quote
$1.15
−$0.07 · -5.74%
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
Latest quote
$1.15
−$0.07 · -5.74%
After-hours
$1.20
+$0.05 · +4.35%
Sep 14, 7:44 PM ET
Regular session · ET · Market data may be delayed.
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
Day range
Current $1.15
52-week range
Current $1.15
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
25
Expensive
Sentiment
42
Mixed
Risk
78
High Risk
Momentum
33
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
Day range
Current $1.15
52-week range
Current $1.15
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 3.14M USD | 1.17M USD |
| Cost of goods sold | — | — | 15.28M USD | 13.63M USD | 10.79M USD |
| Gross profit | — | — | −15.28M USD | −10.49M USD | −9.61M USD |
| Research and development | — | 203.3K USD | 506.24K USD | 903.98K USD | 2.15M USD |
| Selling, general, and administrative | 4.02M USD | 9.23M USD | 13.17M USD | 10.93M USD | 10.36M USD |
| Operating expenses | 4.02M USD | 9.63M USD | −1.61M USD | 11.83M USD | 12.51M USD |
| Interest expense | 206.05K USD | 2.29M USD | 303.97K USD | 291.18K USD | 316.44K USD |
| Depreciation and amortization | — | 904.14K USD | 2.16M USD | 2.02M USD | 1.79M USD |
| Operating income | −4.02M USD | −9.63M USD | −13.67M USD | −22.32M USD | −22.12M USD |
| Net income | −18.49M USD | −149.19M USD | −27.56M USD | −22.16M USD | −22.32M USD |
Company facts updated Sep 15, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$3.00
160.87% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Oct 16, 2023 | 1:20 | — | — |
Stock split | Jan 11, 2017 | 1:30 | — | — |
Effective Oct 16, 2023
1:20
Effective Jan 11, 2017
1:30
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
